Del Rosso James Q., Stein-Gold Linda, Lynde Charles, Tanghetti Emil, Alexis Andrew F.
J Drugs Dermatol. 2019 Dec 1;18(12):205-1208.
Truncal acne – acne vulgaris involving the chest, back, or shoulders – is thought to be present in more than half of patients with acne. Because the study of acne has been focused on the face, there are sparse data in the literature about the clinical characteristics and management options for truncal acne. It is thought that the pathogenic process is similar between the face and the back, suggesting that treatments studied on the face may be suitable for use on the back. It is not uncommon for patients to omit discussion of truncal acne with their treating physician, and it is likely that non-facial acne is under-diagnosed and under-treated. Scarring and pigmentary problems are common sequelae of acne on the trunk, underscoring the need for early and effective treatment as a preventive measure. Truncal acne merits consideration and should be more thoroughly studied. Initiating treatment with a topical retinoid combined with an antimicrobial agent is logical for most patients with truncal acne, and mirrors recommendations for facial acne; however, there are additional considerations for truncal acne such as extension of the lesions, risk of antibiotic resistance due to large surface areas treated for a prolonged duration, accessibility of lesions, and discoloration of clothing or bedding due to topical products. Oral isotretinoin is the treatment of choice when truncal acne is severe. This article reviews available information as well as recent recommendations for treatment. J Drugs Dermatol. 2019;18(12):1205-1208.
躯干痤疮——寻常痤疮累及胸部、背部或肩部——被认为在超过半数的痤疮患者中存在。由于痤疮研究一直聚焦于面部,文献中关于躯干痤疮的临床特征及治疗选择的数据稀少。人们认为面部和背部的致病过程相似,这表明在面部进行研究的治疗方法可能适用于背部。患者未与治疗医生讨论躯干痤疮的情况并不少见,非面部痤疮很可能未得到充分诊断和治疗。瘢痕和色素沉着问题是躯干痤疮常见的后遗症,这突出了作为预防措施进行早期有效治疗的必要性。躯干痤疮值得关注,应进行更深入的研究。对于大多数躯干痤疮患者而言,开始使用外用维甲酸联合抗菌药物进行治疗是合理的,这与面部痤疮的治疗建议一致;然而,对于躯干痤疮还需考虑其他因素,如皮损的范围、因长时间大面积治疗导致抗生素耐药的风险、皮损的可达性以及外用产品导致衣物或被褥变色等问题。当躯干痤疮严重时,口服异维甲酸是治疗的首选。本文综述了现有信息以及近期的治疗建议。《药物皮肤病学杂志》。2019年;18(12):1205 - 1208。